Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5151-5200 of 6048 result(s).
CYDY CytoDyn Inc
06/02/2020 7:09:49 AM
expert reaction to comments report (2)
CYDY CytoDyn Inc
06/01/2020 9:41:20 AM
With the additional hospitals comin (2)
CYDY CytoDyn Inc
05/31/2020 6:46:55 AM
Honest and civil discourse is the o
CYDY CytoDyn Inc
05/31/2020 4:08:15 AM
About as trustworthy as someone fal
CYDY CytoDyn Inc
05/30/2020 3:14:33 PM
FUD
CYDY CytoDyn Inc
05/30/2020 1:04:23 PM
Your comments enforce my concerns;
CYDY CytoDyn Inc
05/30/2020 12:21:37 PM
Like the IL-6 inhibitors, anakinra (1)
CYDY CytoDyn Inc
05/30/2020 12:42:29 AM
It is a rebrand of the original CEO
CYDY CytoDyn Inc
05/29/2020 5:00:24 PM
Pfizer wasn't involved in our study
CYDY CytoDyn Inc
05/29/2020 9:54:22 AM
We went back and forth several time
CYDY CytoDyn Inc
05/28/2020 10:40:29 PM
Is it better to know or to not know (13)
CYDY CytoDyn Inc
05/28/2020 9:46:25 PM
Since CCR5 has been associated with (8)
CYDY CytoDyn Inc
05/26/2020 5:02:34 PM
On the financing side I would bet t (3)
CYDY CytoDyn Inc
05/25/2020 6:17:39 AM
It means using a biomarker as your
CYDY CytoDyn Inc
05/25/2020 5:40:54 AM
Itolizumab is a CD6 receptor inhibi (2)
CYDY CytoDyn Inc
05/24/2020 8:45:47 AM
Or: with the data I have, publicly (4)
CYDY CytoDyn Inc
05/22/2020 8:18:54 PM
What I am telling them is that it i (5)
CYDY CytoDyn Inc
05/22/2020 7:03:34 PM
Both COVID-19 trials are sponsored (1)
CYDY CytoDyn Inc
05/21/2020 7:33:24 AM
I was going to leave that alone bec (6)
CYDY CytoDyn Inc
05/19/2020 9:54:08 AM
Lots of people say it’s a great s (2)
CYDY CytoDyn Inc
05/19/2020 5:09:47 AM
Nader has talked about dividends be (2)
CYDY CytoDyn Inc
05/18/2020 12:44:12 PM
This trial will prove that. I am a (1)
CYDY CytoDyn Inc
05/18/2020 12:02:14 PM
This head to head trial might force (6)
CYDY CytoDyn Inc
05/18/2020 7:52:05 AM
Gilead had just requested a combo t
CYDY CytoDyn Inc
05/18/2020 6:52:11 AM
Time to kick ass and take names. (1)
CYDY CytoDyn Inc
05/17/2020 9:35:39 AM
Take a look at the level of competi
CYDY CytoDyn Inc
05/16/2020 1:47:47 AM
Why interim results are important. (2)
CYDY CytoDyn Inc
05/15/2020 5:54:02 PM
Pre-clinical results only, but what (2)
CYDY CytoDyn Inc
05/15/2020 10:02:45 AM
Leronlimab - Disease List (updated) (14)
CYDY CytoDyn Inc
05/15/2020 7:12:05 AM
Why have one ineffective drug when (4)
CYDY CytoDyn Inc
05/15/2020 6:36:11 AM
Never trust Google translate - is a (1)
CYDY CytoDyn Inc
05/14/2020 2:41:17 AM
For such a study why not have a pla (2)
CYDY CytoDyn Inc
05/13/2020 1:29:39 PM
The two things I found interesting (5)
CYDY CytoDyn Inc
05/12/2020 9:49:23 AM
It just means the SEC accepted the
CYDY CytoDyn Inc
05/12/2020 3:02:35 AM
“The danger is now it’s the tre (4)
CYDY CytoDyn Inc
05/11/2020 10:48:26 AM
Why say BLA is submitted if it is n (4)
CYDY CytoDyn Inc
05/11/2020 10:31:37 AM
Not saying it is but look at it fro (6)
CYDY CytoDyn Inc
05/11/2020 10:23:28 AM
Anyone have any idea what the curre
CYDY CytoDyn Inc
05/11/2020 9:18:59 AM
I've actually had that marked as on (2)
CYDY CytoDyn Inc
05/11/2020 8:09:55 AM
Hydroxychloroquine and azithromycin (5)
CYDY CytoDyn Inc
05/10/2020 10:03:55 PM
It wasn't from the last live video,
CYDY CytoDyn Inc
05/10/2020 7:59:59 AM
Measles, Mumps and Rubella are comp (4)
CYDY CytoDyn Inc
05/09/2020 6:37:43 AM
Gilead will be flying some remdesiv (2)
CYDY CytoDyn Inc
05/09/2020 2:41:10 AM
And contact the Boston Globe about
CYDY CytoDyn Inc
05/08/2020 2:53:52 PM
Baricitinib is a Jak1/Jak2 inhibito (3)
CYDY CytoDyn Inc
05/08/2020 2:00:43 PM
The law forms are only "investigati
CYDY CytoDyn Inc
05/08/2020 1:38:24 PM
Mock datasets show the FDA in what
CYDY CytoDyn Inc
05/08/2020 1:28:20 PM
Here is exactly what was said. It w (1)
CYDY CytoDyn Inc
05/08/2020 10:28:28 AM
What litigation? If any law firm wa
CYDY CytoDyn Inc
05/07/2020 11:32:28 AM
England has compassionate use. Sara (1)
Go to page:
  • << First
  • < Previous
  • 103
  • 104
  • Next >

Recent Articles

  • Charlie Kirk's Final Thoughts on Success and Entrepreneurship
  • Tracer's Innovative IEO Launch on Coinstore Revolutionizes Carbon Market
  • Goldragon Transforms GameFi with Innovative Staking and Governance
  • Convenience Stores Challenge Fast-Food Chains for Breakfast Sales
  • Essential Guidance for Families in Interpleader Lawsuits
  • Sasken and VicOne Unite for Cutting-Edge Automotive Security
  • Investors Can Lead Tronox Holdings plc Class Action Lawsuit
  • Investors Review V.F. Corporation Class Action Lawsuit Insights
  • Sasken and VicOne Unite for Advanced Automotive Security Solutions
  • A Deep Dive into AI Growth and Its Impact on Industries
  • Trump's Shift on Taiwan Military Support: Implications Ahead
  • Navigating the Frontier of Artificial Superintelligence
  • Discover AIMOON: A New Era in AI and Web3 Interactions
  • Investors of V.F. Corporation Can Pursue Class Action Claims
  • Farm Aid 40: Honoring Legacy and Addressing Future Challenges
  • Flying Taxi Market Warriors: Who Will Dominate the Sky?
  • VAPORESSO's XROS PRO 2: A New Era for Vaping Excellence
  • Senate Standoff: Shifting Dynamics and Government Shutdown Risk
  • Celebrating Heritage: Spencer Tunick's Art for 100 Years of Alhambra
  • VAPORESSO Unveils Cutting-Edge XROS PRO 2 for Vaping Enthusiasts
  • C4 Therapeutics Unveils Exciting Cemsidomide Data for Myeloma
  • How Ride-Hailing Services Stand to Win from Autonomous Vehicles
  • Adrian Grenier Embraces Eco-Luxury with New Kitchen Design
  • Important Update on Spectrum Pharmaceuticals Lawsuit
  • Huawei Leads Global Initiatives for Intelligent Transformation in Data Communication
  • Replimune Faces Significant Share Drop Amid Drug Approval Setbacks
  • Discover the Benefits of the Flixy Streaming Device Now
  • Investors Seek Justice as Lockheed Martin Faces Lawsuit Allegations
  • Investors Seek Justice Against Sable Offshore in New Case
  • Exciting Updates on Ozak AI: Presale Hits $3.3M, Gains Ahead
  • Discover Remittix: Your Gateway to a Crypto Revolution
  • Navigating the Job Market: AI's Impact on New Graduates
  • Xinjiang's Prosperity: Transformative Developments in the Region
  • Can Coatings Market Growth Projection for Sustainable Future
  • How Yiwugo Merchants Thrive on IP Products in Today's Market
  • Trump's Controversial Take on Media Coverage: A Deeper Analysis
  • GCUPRI Launches New Website to Promote Global Peace Efforts
  • Discovering the Growth of Triazine Market by 2030
  • Expert Forecasts Bitcoin's Bright Future and New Support Levels
  • Join the Wave: KBR, Inc. Class Action Securities Lawsuit
  • Investors Urge RevoluGROUP to Address Governance Issues Promptly
  • Revitalizing Governance in RevoluGROUP: A Shareholder's Plea
  • Investors in RxSight, Inc. Urged to Join Securities Lawsuit
  • LISEN Introduces Innovative Power Banks for iPhone 17 Users
  • Top Electrical Equipment Stocks Experience Momentum Surge
  • MT Højgaard Danmark Takes Charge of Exciting Metro Expansion
  • Key Stocks Making Waves: Intel, FedEx, Cracker Barrel Insights
  • Investors of Jasper Therapeutics Face Class Action Insights
  • Charter Communications Faces Legal Challenges Amid Stock Drop
  • Legal Update on Lineage, Inc.: Investor Class Action Lawsuit
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site